中国医药等多家上市公司披露称参与第十一批全国药品集中采购拟中选

Core Viewpoint - Multiple listed companies in China, including China Medical, Guoyao Modern, ST Nuotai, Yuandong Bio, Fuan Pharmaceutical, and Jiutian Pharmaceutical, announced their participation in the 11th batch of national centralized drug procurement, with some products expected to be selected for this procurement [1] Group 1: Company Announcements - China Medical's subsidiary, Tianfang Pharmaceutical Co., Ltd., participated in the bidding for the 11th batch of national drug centralized procurement, with its product Nicardipine tablets expected to be selected [1] - ST Nuotai announced that its product Agomelatine tablets is also expected to be selected in this centralized procurement, which could enhance sales scale, expand cooperation channels, and improve brand influence, positively impacting future operating performance [1]